Related Experiment Video
Updated: Oct 8, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Regulating NETosis: An emerging facet of statin pleiotropy
Shabnam Radbakhsh1, Petri T Kovanen2, Amirhossein Sahebkar3
1Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
NETosis has emerged as a new player in the pathogenesis of several diseases including atherosclerotic cardiovascular disease. There is accumulating evidence suggesting that NETosis is regulated by statins, thereby justifying an important lipid-independent pleiotropic action of statin drugs in reducing the risk of atherothrombosis as well as other pathologies.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Regulation of Nuclear Protein Sorting
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Angiogenesis and Blood Supply
Regulation of Metabolism
The JAK-STAT Signaling Pathway